Intrahepatic cholangiocarcinoma: Rising frequency, improved survival, and determinants of outcome after resection
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
At Memorial Sloan-Kettering Cancer Center, IHC incidence has increased dramatically in the last 16 years. Resection offers the best opportunity for long-term survival but is possible in the minority, and patients with large, node-positive or multifocal IHC seem to derive little benefit. Establishing and maintaining control of the intrahepatic disease remains the biggest problem for all IHC patients. The recent increase in survival seems largely because of improved nonoperative therapy for unresectable disease.